Tvardi Therapeutics (TVRD) Equity Ratio (2016 - 2025)
Tvardi Therapeutics' Equity Ratio history spans 13 years, with the latest figure at 0.65 for Q4 2025.
- On a quarterly basis, Equity Ratio rose 125.22% to 0.65 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.65, a 125.22% increase, with the full-year FY2025 number at 0.65, up 125.22% from a year prior.
- Equity Ratio hit 0.65 in Q4 2025 for Tvardi Therapeutics, down from 0.71 in the prior quarter.
- Over the last five years, Equity Ratio for TVRD hit a ceiling of 0.92 in Q1 2021 and a floor of 2.59 in Q4 2024.
- Historically, Equity Ratio has averaged 0.14 across 5 years, with a median of 0.78 in 2023.
- Biggest five-year swings in Equity Ratio: tumbled 425.01% in 2024 and later soared 174.67% in 2025.
- Tracing TVRD's Equity Ratio over 5 years: stood at 0.92 in 2021, then fell by 5.39% to 0.87 in 2022, then tumbled by 156.6% to 0.49 in 2023, then plummeted by 425.01% to 2.59 in 2024, then soared by 125.22% to 0.65 in 2025.
- Business Quant data shows Equity Ratio for TVRD at 0.65 in Q4 2025, 0.71 in Q3 2025, and 0.75 in Q2 2025.